- Home
- Browse
- National Institutes of Health
- PAR-25-383
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
- Deadline
- 2026-09-28
- 25 days left
- Award ceiling
- —
- Awards
- —
- Posted
- 2025-06-17
Summary
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to pursue translational activities and clinical studies to advance the development of medical devices to prevent, monitor, diagnose, and treat disorders within the missions of the participating NIH institutes and centers, as well as the NIH Brain… […]
The rest of this announcement — free with an account
- →The full announcement text, not the first two sentences
- →All 3 review criteria reviewers score this against, extracted from this announcement
- →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- →What similar funded projects received, from 219,000 past awards
No card required. Browsing and your first match are free.
More from National Institutes of Health
See all →NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.
3 review criteria on fileNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileAlso in neuroscience
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function.
3 review criteria on fileCellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function.
3 review criteria on fileTranslational Neural Devices (R61/R33 - Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems.
3 review criteria on fileOfficial announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-383.htmlSource: nih_guide+grants_gov. Always confirm dates with the funder.